BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1295 related articles for article (PubMed ID: 18042143)

  • 41. [Epigenetic processes in malignant transformation: the role of DNA methylation in cancer development].
    Suijkerbuijk KP; van der Wall E; van Laar T; Vooijs M; van Diest PJ
    Ned Tijdschr Geneeskd; 2007 Apr; 151(16):907-13. PubMed ID: 17500342
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gene silencing by DNA methylation in haematological malignancies.
    Boultwood J; Wainscoat JS
    Br J Haematol; 2007 Jul; 138(1):3-11. PubMed ID: 17489980
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DNA methylation alterations in multiple myeloma as a model for epigenetic changes in cancer.
    Sharma A; Heuck CJ; Fazzari MJ; Mehta J; Singhal S; Greally JM; Verma A
    Wiley Interdiscip Rev Syst Biol Med; 2010; 2(6):654-69. PubMed ID: 20890963
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Histone modifying and chromatin remodelling enzymes in cancer and dysplastic syndromes.
    Gibbons RJ
    Hum Mol Genet; 2005 Apr; 14 Spec No 1():R85-92. PubMed ID: 15809277
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The clinical application of targeting cancer through histone acetylation and hypomethylation.
    Gilbert J; Gore SD; Herman JG; Carducci MA
    Clin Cancer Res; 2004 Jul; 10(14):4589-96. PubMed ID: 15269129
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DNA methylation and cancer.
    Kulis M; Esteller M
    Adv Genet; 2010; 70():27-56. PubMed ID: 20920744
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The dialectics of cancer: A theory of the initiation and development of cancer through errors in RNAi.
    Wynter CV
    Med Hypotheses; 2006; 66(3):612-35. PubMed ID: 16359827
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DNA methylation-mediated epigenetic control.
    Rottach A; Leonhardt H; Spada F
    J Cell Biochem; 2009 Sep; 108(1):43-51. PubMed ID: 19565567
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epigenetic gene regulation in cancer.
    Ballestar E; Esteller M
    Adv Genet; 2008; 61():247-67. PubMed ID: 18282509
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epigenetic mechanisms in AML - a target for therapy.
    Oki Y; Issa JP
    Cancer Treat Res; 2010; 145():19-40. PubMed ID: 20306243
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues.
    Al-Mahdawi S; Pinto RM; Ismail O; Varshney D; Lymperi S; Sandi C; Trabzuni D; Pook M
    Hum Mol Genet; 2008 Mar; 17(5):735-46. PubMed ID: 18045775
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epigenetic biomarkers in urothelial bladder cancer.
    Kim WJ; Kim YJ
    Expert Rev Mol Diagn; 2009 Apr; 9(3):259-69. PubMed ID: 19379084
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
    Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ
    Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Towards targeted epigenetic therapy of cancer.
    Magic Z; Supic G; Brankovic-Magic M
    J BUON; 2009 Sep; 14 Suppl 1():S79-88. PubMed ID: 19785074
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of mammalian DNA methyltransferases in the regulation of gene expression.
    Turek-Plewa J; JagodziƄski PP
    Cell Mol Biol Lett; 2005; 10(4):631-47. PubMed ID: 16341272
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DNA methylation: the nuts and bolts of repression.
    Miranda TB; Jones PA
    J Cell Physiol; 2007 Nov; 213(2):384-90. PubMed ID: 17708532
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aberrant gene silencing in tumor progression: implications for control of cancer.
    Baylin SB; Chen WY
    Cold Spring Harb Symp Quant Biol; 2005; 70():427-33. PubMed ID: 16869780
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epigenetic tools in potential anticancer therapy.
    Sebova K; Fridrichova I
    Anticancer Drugs; 2010 Jul; 21(6):565-77. PubMed ID: 20436342
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [DNA methylation--alternative mechanism of chemical carcinogenesis].
    Kostka G; Urbanek K
    Rocz Panstw Zakl Hig; 2005; 56(1):1-14. PubMed ID: 16080440
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epigenome: a new target in cancer therapy.
    Giacinti L; Vici P; Lopez M
    Clin Ter; 2008; 159(5):347-60. PubMed ID: 18998037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 65.